Latest News

Mary Aaland, MD, FACS, Appointed to ND Medicaid Drug Utilization Review Board

Posted 6/28/19 (Fri)

This week, NDMA member Dr. Mary Aaland was appointed to the ND Medicaid Drug Utilization Review (DUR) Board by NDMA President Fadel Nammour, MD.

The DUR Board's functions include serving as an advisory board for policies, identifying and developing educational topics for practitioners to improve drug therapy, and assisting the department in identifying patterns of fraud, abuse, gross overuse, or inappropriate or medically unnecessary care.

The DUR Board includes six physicians, six pharmacists, and three non-voting members as outlined by State Law and Administrative Rules. 

Other NDMA members serving on the board include: A. Michael Booth, MD; Jeffrey Hostetter, MD; Michael Quast, MD; and Laura Schield, MD. Dr. Aaland will replace Dr. Jeffrey Hostetter, whose term is due to expire soon.

Congratulations to Dr. Aaland!